- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 281/16 - [b, f]-condensed
Patent holdings for IPC class C07D 281/16
Total number of patents in this class: 64
10-year publication summary
|
5
|
6
|
4
|
1
|
7
|
0
|
4
|
1
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3002 |
12 |
| Assembly Biosciences, Inc. | 102 |
8 |
| Indiana University Research and Technology Corporation | 783 |
6 |
| AstraZeneca AB | 2820 |
2 |
| Janssen Pharmaceutica N.V. | 3160 |
2 |
| The Trustees of Columbia University in the City of New York | 3645 |
2 |
| ACADIA Pharmaceuticals Inc. | 192 |
2 |
| Baruch S. Blumberg Institute | 35 |
2 |
| Drexel University | 996 |
2 |
| Pontificia Universidad Catolica de Chile | 315 |
2 |
| Actavis Group PTC ehf | 393 |
1 |
| Alembic Limited | 36 |
1 |
| Alla Chem, LLC | 51 |
1 |
| Auspex Pharmaceuticals, Inc. | 131 |
1 |
| "biointegrator" Limited Liability Company (ooo "biointegrator") | 1 |
1 |
| CEA | 7 |
1 |
| Cellixbio Private Limited | 142 |
1 |
| Emory University | 1724 |
1 |
| Fermion Oy | 13 |
1 |
| Hadasit Medical Research Services and Development Ltd. | 322 |
1 |
| Other owners | 14 |